287 related articles for article (PubMed ID: 20961245)
1. Expression of follicle-stimulating hormone receptor in tumor blood vessels.
Radu A; Pichon C; Camparo P; Antoine M; Allory Y; Couvelard A; Fromont G; Hai MT; Ghinea N
N Engl J Med; 2010 Oct; 363(17):1621-30. PubMed ID: 20961245
[TBL] [Abstract][Full Text] [Related]
2. Expression and cellular localization of follicle-stimulating hormone receptor in normal human prostate, benign prostatic hyperplasia and prostate cancer.
Mariani S; Salvatori L; Basciani S; Arizzi M; Franco G; Petrangeli E; Spera G; Gnessi L
J Urol; 2006 Jun; 175(6):2072-7; discussion 2077. PubMed ID: 16697805
[TBL] [Abstract][Full Text] [Related]
3. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR
Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948
[TBL] [Abstract][Full Text] [Related]
4. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
Prewett M; Huber J; Li Y; Santiago A; O'Connor W; King K; Overholser J; Hooper A; Pytowski B; Witte L; Bohlen P; Hicklin DJ
Cancer Res; 1999 Oct; 59(20):5209-18. PubMed ID: 10537299
[TBL] [Abstract][Full Text] [Related]
5. Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone.
Zheng W; Lu JJ; Luo F; Zheng Y; Feng Yj; Felix JC; Lauchlan SC; Pike MC
Gynecol Oncol; 2000 Jan; 76(1):80-8. PubMed ID: 10620446
[TBL] [Abstract][Full Text] [Related]
6. Identification of a high molecular weight endothelial cell surface glycoprotein, endoGlyx-1, in normal and tumor blood vessels.
Sanz-Moncasi MP; Garin-Chesa P; Stockert E; Jaffe EA; Old LJ; Rettig WJ
Lab Invest; 1994 Sep; 71(3):366-73. PubMed ID: 7933987
[TBL] [Abstract][Full Text] [Related]
7. Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade.
Li H; Gerald WL; Benezra R
Cancer Res; 2004 Sep; 64(17):6137-43. PubMed ID: 15342397
[TBL] [Abstract][Full Text] [Related]
8. Nestin-linked green fluorescent protein transgenic nude mouse for imaging human tumor angiogenesis.
Amoh Y; Yang M; Li L; Reynoso J; Bouvet M; Moossa AR; Katsuoka K; Hoffman RM
Cancer Res; 2005 Jun; 65(12):5352-7. PubMed ID: 15958583
[TBL] [Abstract][Full Text] [Related]
9. Vascular Endothelial FSH Receptor, a Target of Interest for Cancer Therapy.
Ghinea N
Endocrinology; 2018 Sep; 159(9):3268-3274. PubMed ID: 30113652
[TBL] [Abstract][Full Text] [Related]
10. Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts.
Kennel SJ; Falcioni R; Wesley JW
Cancer Res; 1991 Mar; 51(5):1529-36. PubMed ID: 1997194
[TBL] [Abstract][Full Text] [Related]
11. VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors.
Petrova TV; Bono P; Holnthoner W; Chesnes J; Pytowski B; Sihto H; Laakkonen P; Heikkilä P; Joensuu H; Alitalo K
Cancer Cell; 2008 Jun; 13(6):554-6. PubMed ID: 18538738
[No Abstract] [Full Text] [Related]
12. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis.
Sinha AA; Gleason DF; Staley NA; Wilson MJ; Sameni M; Sloane BF
Anat Rec; 1995 Mar; 241(3):353-62. PubMed ID: 7538734
[TBL] [Abstract][Full Text] [Related]
14. Anti-human FSH receptor monoclonal antibodies: immunochemical and immunocytochemical characterization of the receptor.
Vannier B; Loosfelt H; Meduri G; Pichon C; Milgrom E
Biochemistry; 1996 Feb; 35(5):1358-66. PubMed ID: 8634264
[TBL] [Abstract][Full Text] [Related]
15. Production of two novel monoclonal antibodies that distinguish mouse lymphatic and blood vascular endothelial cells.
Ezaki T; Kuwahara K; Morikawa S; Shimizu K; Sakaguchi N; Matsushima K; Matsuno K
Anat Embryol (Berl); 2006 Oct; 211(5):379-93. PubMed ID: 16685512
[TBL] [Abstract][Full Text] [Related]
16. Targeted expression of human FSH receptor Asp567Gly mutant mRNA in testis of transgenic mice: role of human FSH receptor promoter.
Nordhoff V; Gromoll J; Foppiani L; Luetjens CM; Schlatt S; Kostova E; Huhtaniemi I; Nieschlag E; Simoni M
Asian J Androl; 2003 Dec; 5(4):267-75. PubMed ID: 14695976
[TBL] [Abstract][Full Text] [Related]
17. Hormone-refractory prostate cancer cells express functional follicle-stimulating hormone receptor (FSHR).
Ben-Josef E; Yang SY; Ji TH; Bidart JM; Garde SV; Chopra DP; Porter AT; Tang DG
J Urol; 1999 Mar; 161(3):970-6. PubMed ID: 10022736
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional modifications of sertoli cells in the testis of adult follicle-stimulating hormone receptor knockout mice.
Grover A; Sairam MR; Smith CE; Hermo L
Biol Reprod; 2004 Jul; 71(1):117-29. PubMed ID: 14998910
[TBL] [Abstract][Full Text] [Related]
19. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility.
Kumar TR; Wang Y; Lu N; Matzuk MM
Nat Genet; 1997 Feb; 15(2):201-4. PubMed ID: 9020850
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing converts the G-protein coupled follitropin receptor gene into a growth factor type I receptor: implications for pleiotropic actions of the hormone.
Sairam MR; Jiang LG; Yarney TA; Khan H
Mol Reprod Dev; 1997 Dec; 48(4):471-9. PubMed ID: 9364441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
